Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma

Clinical trial NCT02709226 · COMPLETED

Trial details

NCT number: NCT02709226
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Astrocytoma, Grade IV Giant Cell Glioblastoma Glioblastoma Multiforme Gliosarcoma

Start date: 2016-06-15
Primary completion: 2022-12-16
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.